Ventavis
Payments companies reported to CMS as associated with Ventavis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ventavis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ventavis
These are the largest totals companies reported as associated with Ventavis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lana Melendres Groves | Albuquerque, NM | Pulmonary Disease | $1,350.00 |
| Nafis Shamsid-Deen | Phoenix, AZ | Internal Medicine | $1,090.00 |
| Brenda Pacheco | Acoma, NM | Medical | $489.00 |
| Charles Gallegos | Albuquerque, NM | Family | $350.00 |
| Gurpreet Sodhi | Sacramento, CA | Advanced Heart Failure and Transplant Cardiology | $22.52 |
| Michael Tao | Middletown, CT | Cardiovascular Disease | $16.08 |
| On Chen | Stony Brook, NY | Interventional Cardiology | $16.08 |
| Ian Gilchrist | Plainview, NY | Interventional Cardiology | $16.08 |
Prescribed Ventavis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.